Professor of Pathology, Weill Cornell Medical Director, Pulmonary Pathology, Houston Methodist
Pathology
Dr. Philip T. Cagle, MD
|
|
Give Review
Philip Cagle practices Pathology. He went to medical school at Baylor College of Medicine. He received awards:"America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Super Doctor". Doctor Philip T. Cagle, MD is a published doctor and has 65 publications published. The lastest was: 'A New Ever-Evolving Paradigm.' Doctor Philip T. Cagle, MD accepts all Medicare patients.
Publications
- The 2015 Physician Quality Reporting System Reflects Pathologists' Role in Lung Cancer Biomarker Testing.
- A New Ever-Evolving Paradigm.
- Peripheral lung adenocarcinomas with KRAS mutations are more likely to invade visceral pleura.
- Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.
- Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation.
- Whole slide images add value to journal article figures.
- EGFR Mutations in US Hispanic Versus Non-Hispanic White Patients With Lung Adenocarcinoma.
- Well-differentiated Papillary Mesothelioma With Invasive Foci.
- The Presence of Anti-HLA Donor-Specific Antibodies in Lung Allograft Recipients Does Not Correlate With C4d Immunofluorescence in Transbronchial Biopsy Specimens.
- Lung cancer biomarkers: present status and future developments.
- Verifying the role of surgical pathologists in the precision medicine of lung cancer.
- Pulmonary sclerosing papillary adenoma.
- Lung Adenocarcinoma Biomarker Incidence in Hispanic Versus Non-Hispanic White Patients.
- Template for Reporting Results of Biomarker Testing of Specimens From Patients With Non-Small Cell Carcinoma of the Lung.
- p16 Deletion in Sarcomatoid Tumors of the Lung and Pleura.
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group.
- Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, Int...
- The proposed new classification of pulmonary adenocarcinoma and the conservation of small tissue samples for testing.
- Folate Receptor in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: Potential Target for Folate-Linked Therapeutic Agents.
- Pulmonary papillary adenoma: a case report and review of the literature.
- Tissue-Preserving Antibody Cocktails to Differentiate Primary Squamous Cell Carcinoma, Adenocarcinoma, and Small Cell Carcinoma of Lung.
- Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Org...
- Lung cancer genotype-based therapy and predictive biomarkers: present and future.
- Evolving frontlines in the diagnosis and treatment of pulmonary diseases.
- Precision medicine for lung cancer: role of the surgical pathologist.
- The transformation of pathology: proceedings of the houston lung symposium.
- Differential diagnosis of lung carcinoma with three-dimensional quantitative molecular vibrational imaging.
- On-the-spot lung cancer differential diagnosis by label-free, molecular vibrational imaging and knowledge-based classification.
- Genomic pathology: challenges for implementation.
- Increased levels of nuclear factor κB and Fos-related antigen 1 in lung tissues from patients with acute respiratory distress syndrome.
- Lung cancer and the future of pathology.
- Pathologists as leaders, innovators, and devoted physicians: special section on pathology in resource-poor nations.
- Revolution in lung cancer: new challenges for the surgical pathologist.
- Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.
- Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?
- Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates.
- Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis.
- Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
- Basic concepts of molecular pathology.
- Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.
- Expression of activated and latent signal transducer and activator of transcription 3 in 303 non-small cell lung carcinomas and 44 malignant mesotheliomas: possible ro...
- MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival.
- Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung.
- Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression.
- Interpreting the histopathology of chronic cough: a prospective, controlled, comparative study.
- Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell...
- The 100-year anniversary of the description of the frozen section procedure.
- Frozen section of lung specimens.
- Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.
- Review and update of uncommon primary pleural tumors: a practical approach to diagnosis.
- Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer.
- Localized malignant mesothelioma.
- The proposal to close the armed forces institute of pathology.
- Silicone thorax due to a ruptured breast implant.
- Comparison of monoclonal versus polyclonal calretinin antibodies for immunohistochemical diagnosis of malignant mesothelioma.
- Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach.
- Cytomegalovirus infection masquerading as carcinoma in a lung transplant patient.
- Pulmonary and ophthalmic involvement with Erdheim-Chester disease: a case report and review of the literature.
- Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.
- Transforming growth factor alpha and epidermal growth factor receptor in reactive and malignant mesothelial proliferations.
- Nitric oxide and tuberculosis infection.
- Large cell neuroendocrine carcinoma: an unusual presentation.
- Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas.
- Criteria for attributing lung cancer to asbestos exposure.
Schools
University of Tennessee Memphis College of Medicine amp Surgery
Baylor College Of Med
Doctors Specialties
- Pathology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Super Doctor
Education
-
Baylor College of Medicine -
University of Tennessee College of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598713059 |
| Last Name Of The Provider | CAGLE |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
|
Dr. Leonard J. Medeiros, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Syed M. Quadri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claire Langston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milton J. Finegold, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alejandro Contreras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yimin Ge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena G. Nedelcu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Angshumoy Roy, MB
This Doctor is OpenDoctor Recommended.
|